Post-traumatic Stress Disorder (PTSD)
1
Pipeline Programs
4
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Small Molecule
2100%
+ 2 programs with unclassified modality
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Forte BiosciencesTX - Dallas
1 programBlended Trauma-Focused Cognitive Behavioral Therapy with CompassionN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
OtsukaPropranolol
Forte BiosciencesBlended Trauma-Focused Cognitive Behavioral Therapy with Compassion
Colorado TherapeuticsActive Acupressure Treatment
Clinical Trials (3)
Total enrollment: 134 patients across 3 trials
A Trial to Assess the Effects of Prazosin or Propranolol on Blood Pressure in the Presence of Brexpiprazole/Sertraline
Start: Sep 2022Est. completion: Aug 202334 patients
Phase 1Terminated
Blended Trauma-Focused Cognitive Behavioral Therapy With Compassion
Start: Feb 2026Est. completion: Dec 202940 patients
N/ARecruiting
Acupressure and Stress Resilience
Start: Jun 2012Est. completion: Mar 201760 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 134 patients
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.